GILEAD SCIENCES, INC. — Director's Dealing 2019

Feb 8, 2019

SEC Form 4 — Statement of Changes in Beneficial Ownership

Issuer: GILEAD SCIENCES INC (GILD)
CIK: 0000882095
Period of Report: 2019-02-06

Reporting Person: Alton Gregg H (EVP,Corporate &Medical Affairs)

Non-Derivative Transactions

Date	Security	Code	Shares	Price	A/D	Holdings After	Ownership
2019-02-06	Common Stock	A	10109	—	Acquired	54535	Direct
2019-02-06	Common Stock	A	9042	—	Acquired	63577	Direct
2019-02-06	Common Stock	F	5861	$68.75	Disposed	57716	Direct

Derivative Transactions

Date	Security	Exercise Price	Code	Shares	A/D	Expiration	Underlying	Ownership
2019-02-06	Non-qualified Stock Option (Right to Buy)	$68.75	A	63100	Acquired	2029-02-06	Common Stock (63100)	Direct
2019-02-06	Restricted Stock Unit	$	A	13640	Acquired		Common Stock (13640)	Direct

Footnotes

F1: The options have a four year vesting schedule. 25% of the options will vest on the first anniversary date of the grant. The balance will vest 6.25% quarterly thereafter until fully vested.

F2: Each restricted stock unit represents the contingent right to receive one share of Gilead Sciences, Inc.'s common stock.

F3: The restricted stock units have a four year vesting schedule. 25% vest on the anniversary of the date of grant until fully vested.

F4: Represents shares of the Issuer's common stock subject to specific tranches of the performance share awards made to the Reporting Person on February 2, 2017, and February 1, 2018. Such tranches of shares were subject to both performance-vesting and service-vesting requirements. The performance vesting requirement was satisfied on the date reported in Column 2 above upon certification of performance goal attainment by the Compensation Committee of the Issuer's Board of Directors. However, the shares will not be issued to the Reporting Person until such individual upon certification of performance goal attainment by the Compensation Committee of the Issuer's Board of Directors.

F5: Represents shares of the Issuer's common stock subject to specific tranches of the performance share award made to the Reporting Person on February 1, 2016. Such tranches of shares were subject to performance-vesting and service-vesting requirements and became issuable on the date reported in Column 2 above upon certification of performance goal attainment by the Compensation Committee of the Issuer's Board of Directors.